| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4125682 | Otolaryngology - Head and Neck Surgery | 2009 | 7 Pages |
Abstract
Combination of FGF2-Ad-Rad50 with cisplatin significantly improves anti-tumor effect by targeting DNA repair systems and tumor angiogenesis. The great benefit of this strategy supports clinical trial for novel treatment of head and neck squamous cell carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Mindy R. Figures, Jessie Wobb, Koji MD, PhD, Tingyan MD, Lei MD, Hanjing Zhu, Bert W. MD, Daqing MD,